Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations
K. Strong (London, United Kingdom), J. Zhu (London, United Kingdom), D. Jackson (London, United Kingdom), J. Dhariwal (London, United Kingdom), M. Trujillo-Torralbo (London, United Kingdom), S. Johnston (London, United Kingdom), M. Edwards (London, United Kingdom)
Source: International Congress 2018 – Mechanisms of respiratory infection
Session: Mechanisms of respiratory infection
Session type: Thematic Poster
Number: 2647
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Strong (London, United Kingdom), J. Zhu (London, United Kingdom), D. Jackson (London, United Kingdom), J. Dhariwal (London, United Kingdom), M. Trujillo-Torralbo (London, United Kingdom), S. Johnston (London, United Kingdom), M. Edwards (London, United Kingdom). Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations. 2647
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: